Publications (10) MARYCARMEN AREVALO MARTINEZ publications

2024

  1. Myocardin related transcription factor and galectin-3 drive lipid accumulation in human blood vessels

    Vascular Pharmacology, Vol. 156

2023

  1. Itga8-Cre-mediated deletion of YAP and TAZ impairs bladder contractility with minimal inflammation and chondrogenic differentiation

    American Journal of Physiology - Cell Physiology, Vol. 325, Núm. 6, pp. C1485-C1501

  2. Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta

    JCI Insight, Vol. 8, Núm. 17

2022

  1. Role of smooth muscle YAP and TAZ in protection against phenotypic modulation, inflammation, and aneurysm development

    Biochemical Pharmacology, Vol. 206

  2. YAP and TAZ in Vascular Smooth Muscle Confer Protection Against Hypertensive Vasculopathy

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 42, Núm. 4, pp. 428-443

2021

  1. Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation

    Journal of Cellular Physiology, Vol. 236, Núm. 6, pp. 4330-4347

  2. miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers

    Molecular Metabolism, Vol. 53

2020

  1. Elastin-like recombinamer-based devices releasing Kv1.3 blockers for the prevention of intimal hyperplasia: An in vitro and in vivo study

    Acta Biomaterialia, Vol. 115, pp. 264-274

2019

  1. Myocardin-Dependent Kv1.5 Channel Expression Prevents Phenotypic Modulation of Human Vessels in Organ Culture

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 12, pp. E273-E286

2015

  1. Identificación de parámetros normales de la arteria renal en caninos clínicamente sanos de talla pequeña por medio de doppler color pulsado

    TRIM: Tordesillas, revista de investigación multidisciplinar, Núm. 9, pp. 47-54